FF-10101-01 Uses, Dosage, Side Effects and more
FF-10101-01 is under investigation in clinical trial NCT03194685 (Study of FF-10101-01 in Patients With Relapsed or Refractory Acute Myeloid Leukemia).
| Trade Name | FF-10101-01 |
| Generic | FF-10101-01 |
| Type | |
| Formula | C29H38N8O2 |
| Weight | Average: 530.677 Monoisotopic: 530.311772496 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
